ArticleObesity (Silver Spring, Md.)2025

Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).

Sean Wharton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.